In a retrospective analysis, researchers assessed the effect of CoQ10 supplementation in pediatric patients diagnosed with new daily persistent headache.
In a phase 3, randomized, double-blind, placebo-controlled study, researchers assessed the safety and efficacy of fremanezumab for the prevention of headaches due to migraine in children and adolescents with episodic migraine.
You’ve read {{metering-count}} of {{metering-total}} articles this month.
We want you to take advantage of everything Neurology Advisor has to offer. To view unlimited content, log in or register for free.
{{login-button}} {{register-button}}
Want to view more content from Neurology Advisor?
Register now at no charge to access unlimited clinical news with personalized daily picks for you, full-length features, case studies, conference coverage, and more.
{{login-button}} {{register-button}}
Please login or register first to view this content.
